Rapid decline of residual renal function in patients with late renal transplant failure who are re-treated with CAPD

Peritoneal Dialysis International

Volumn 23, Issue 4, 2003, Pages 398-400

  Schiffl, Helmut ^a   Mücke, Claudia ^a   Lang, Susanne M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOSPORIN; ERYTHROPOIETIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; TIME FACTORS; URINARY TRACT PHYSIOLOGY;

EID: 0042420730     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Van Biesen W, Davies S, Lameire N. An integrated approach to end-stage renal disease. Nephrol Dial Transplant 2001; 16(Suppl 6):7-9.
2. Szeto CC, Lai KN, Wong TY, Law MC, Leung CB, Yu AW, et al. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1999; 34:1056-64.
3. Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000; 20: 439-44.
4. Bargman JM, Thorpe KE, Churchill D. Relative contribution of residual and peritoneal clearance to adequacy of dialysis. A reanalysis of the CANUSA Study. J Am Soc Nephrol 2001; 12:2158-62.
5. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-53.
6. Andrews PA, Warr KJ, Hicks JA, Cameron JS. Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients. Nephrol Dial Transplant 1996; 11:1104-8.
7. Smak Gregoor PJH, Zietse R, Van Saase JLCM, op de Hoek CT, Ijzermans JNM, Lavarijssen ATJ, et al. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 2001; 15: 397-401.
8. Sasal J, Naimark D, Klassen J, Shea J, Bargman JM. Late renal transplant failure: an adverse prognostic factor at initiation of peritoneal dialysis. Perit Dial Int 2001; 21:405-10.
9. Jassal SV, Lok CE, Walele A, Bargman JM. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis 2002; 40:178-83.
10. Davies SJ. Peritoneal dialysis in the patient with a failing renal allograft. Perit Dial Int 2001; 21(Suppl 3): S280-4.
11. Wilmer WA, Pesavento TE, Bay WH, Middendorf DF, Donelan SE, Frabott SM, et al. Peritoneal dialysis following failed kidney transplantation is associated with high peritoneal transport rates. Perit Dial Int 2001; 21:411-13.